Rhythm Pharmaceuticals' high P/S ratio and unstable revenue ...
Rhythm Pharmaceuticals' high P/S ratio and unstable revenue growth could be alarming for investors. Given the weak revenue forecast, share prices may risk a decline. Investor caution is advised.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000290b150965418f.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment